UK markets closed

Sartorius Aktiengesellschaft (0NIQ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
372.94+3.00 (+0.81%)
At close: 4:58PM BST

Sartorius Aktiengesellschaft

Otto-Brenner-Strasse 20
Göttingen 37079
Germany
49 551 308 0
http://www.sartorius.com

Sector(s)
Industry
Full-time employees11,000

Key executives

NameTitlePayExercisedYear born
Dr. Joachim KreuzburgChairman of Exec. Board & CEO1.46MN/A1965
Mr. Rainer LehmannCFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process825kN/A1975
Dr. Rene FaberHead of Bioprocess Solutions Division & Member of Exec. Board714kN/A1975
Ms. Petra KirchhoffHead of Corp. Communications & Investor Relations and Member of Supervisory Board56kN/A1969
Mr. John Gerard MackayHead of Lab Products & Services Division and Member of Exec. BoardN/AN/A1962
Mr. Manfred WernerSr. VP of Admin. Organization & AuditingN/AN/AN/A
Ms. Mei WangHead of Production - ChinaN/AN/AN/A
Ms. Patricia SpannagelHead of Quality Assurance - Mechatronics Division GoettingenN/AN/AN/A
Mr. Rashid MaqboolHead of Production & Certification Department - Denver USAN/AN/AN/A
Mr. Manohar KuppusamiHead of Production Department - IndiaN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Corporate governance

Sartorius Aktiengesellschaft’s ISS governance QualityScore as of 30 April 2021 is 7. The pillar scores are Audit: 1; Board: 6; Shareholder rights: 10; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.